Tamoxifen for hepatocellular carcinoma

Cochrane Database Syst Rev. 2020 Aug 3;8(8):CD001024. doi: 10.1002/14651858.CD001024.pub3.

Authors

Anna K Nowak¹, Michael Findlay², Gordana Culjak³, Martin R Stockler⁴

Affiliations

¹ Department of Medical Oncology, Sir Charles Gairdiner Hospital and University of Western Australia, Perth, Australia.
² Director, Cancer Trials New Zealand, Faculty of Medical & Health Sciences, Auckland, New Zealand.
³ Sydney Medical School, Sydney, Australia.
⁴ NHMRC Clinical Trials Centre and Sydney Cancer Centre, The University of Sydney, Camperdown, Australia.

Abstract

The review is withdrawn as it has not been updated since its last search for trials in 2004.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Publication types

Review
Research Support, Non-U.S. Gov't